Work

Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival

Year: 2005

Type: article

Source: Molecular Pharmacology

DOI: 10.1124/mol.105.012716

Authors: Larry M. Karnitz, Karen S. Flatten, Jill M. Wagner, David Loegering, Jennifer S. Hackbarth, Sonnet J.H. Arlander, Benjamin T. Vroman, M. Bijoy Thomas, Yong-Un Baek, Kevin M. Hopkins, Howard B. Lieberman, Junjie Chen, William A. Cliby, Scott H. Kaufmann

Institutions: Mayo Clinic, Columbia University

Language: English

Topic: DNA Repair Mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences

Awards: Mechanisms of Radioresistance and Cell Cycle Progression, G2176962616, G2848872078, G4901467029, G5404242371, G6855855148, Mrad9 Radioresistance Gene, Study the Role of DNA Damage Responses in Tumorigenesis, G97335616

OpenAlex ID: W2126583326

FWCI: 2.188

Cites: 42

Cited by: 137

Related to: 10